<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
APGE
Apogee Therapeutics
$
()


  • Spyre Therapeutics price target raised by $18 at Stifel, here's why

    3/25/2024 - 17:17pm
  • Apogee announces first participants dosed in Phase 1 trial of APG808

    3/25/2024 - 07:03am
  • Four new option listings on March 20th

    3/20/2024 - 08:31am
  • Apogee Therapeutics 6.77M share Secondary priced at $62.00

    3/7/2024 - 18:55pm
  • Apogee Therapeutics announces $350M common stock offering

    3/5/2024 - 16:24pm
  • What You Missed On Wall Street On Tuesday

    3/5/2024 - 16:21pm
  • Apogee Therapeutics files to sell 6M shares of common stock

    3/5/2024 - 16:11pm
  • Apogee Therapeutics price target raised by $49 at Stifel, here's why

    3/5/2024 - 13:10pm
  • What You Missed On Wall Street This Morning

    3/5/2024 - 11:59am
  • Apogee Therapeutics price target raised by $47 at Guggenheim, here's why

    3/5/2024 - 06:26am
  • Apogee Therapeutics reports Q4 net loss $31.7M vs. $14M last year

    3/5/2024 - 06:15am
  • Apogee Therapeutics' APG777 shows positive Phase 1 results in dermatitis

    3/5/2024 - 06:06am
  • Spyre Therapeutics price target raised by $9 at Stifel, here's why

    1/12/2024 - 07:36am
  • Apogee Therapeutics price target raised by $12 at Stifel, here's why

    1/12/2024 - 07:35am
  • Apogee Therapeutics price target raised by $15 at Guggenheim, here's why

    1/3/2024 - 09:13am
dynamic_feed Breaking News